As Nrf2 deficiency improved cytokine production, we determined the in vivo anti-tumor activity of Nrf2-deficient OT-I cells using a solid tumor model with B16-OVA and E.G7-OVA (Figure 2B). Here, NFE2L2 is linked to neoplasm.